Format

Send to

Choose Destination
Sci Transl Med. 2016 Jul 27;8(349):349lr1. doi: 10.1126/scitranslmed.aag1805.

Response to comment on "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis".

Author information

1
Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
2
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
3
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA. fnf7703@hotmail.com yushicang@163.com dzhang@pharmacy.arizona.edu.
4
Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China. fnf7703@hotmail.com yushicang@163.com dzhang@pharmacy.arizona.edu.
5
Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China. fnf7703@hotmail.com yushicang@163.com dzhang@pharmacy.arizona.edu.

Abstract

Multiple factors may affect the outcome of diabetic patients with cancer treated with antioxidant antidiabetic agents.

PMID:
27464746
DOI:
10.1126/scitranslmed.aag1805
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center